| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | MDA01-01-4738 | Treatment:MDA | AU |
| Reversed phase POSITIVE ION MODE | MDA01-02-4739 | Treatment:MDA | AU |
| Reversed phase POSITIVE ION MODE | MDA02-01-4740 | Treatment:MDA | AU |
| Reversed phase POSITIVE ION MODE | MDA02-02-4741 | Treatment:MDA | AU |
| Reversed phase POSITIVE ION MODE | MDA03-01-4742 | Treatment:MDA | AU |
| Reversed phase POSITIVE ION MODE | MDA03-02-4743 | Treatment:MDA | AU |
| Reversed phase POSITIVE ION MODE | REL01-01-4732 | Treatment:REL | AU |
| Reversed phase POSITIVE ION MODE | REL01-02-4733 | Treatment:REL | AU |
| Reversed phase POSITIVE ION MODE | REL02-01-4734 | Treatment:REL | AU |
| Reversed phase POSITIVE ION MODE | REL02-02-4735 | Treatment:REL | AU |
| Reversed phase POSITIVE ION MODE | REL03-01-4736 | Treatment:REL | AU |
| Reversed phase POSITIVE ION MODE | REL03-02-4737 | Treatment:REL | AU |
Return to study ST002910 main page
Download data matrix(Identifying the impact of RelA overexpression in triple negative breast cancer cells using mass spectroscopy-based proteomics and metabolomics analysis Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|